GlassScriptPhysician profile
Mark Phillip Sherman
NPI 1720377799
$4,897.90
in general payments reported to CMS, 2019-2025
19 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,590 · 2020: $239 · 2021: $299 · 2022: $159 · 2023: $320 · 2024: $154 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $474 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $473.87 |
| Education | $137.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $2,951.43 | 2019-2021 | |
| Ocular Therapeutix, INC. | $312.13 | 2019-2024 | Dextenza |
| Ivantis, INC | $281.19 | 2019-2021 | |
| Optos, INC. | $177.91 | 2019-2021 | |
| Abbvie INC. | $177.13 | 2022-2023 | Lumigan, Alphagan P |
| Rxsight INC | $140.11 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Davol INC. | $137.38 | 2025 | Phasix Mesh |
| Aerie Pharmaceuticals, INC. | $133.72 | 2019-2021 | |
| Allergan, INC. | $125.90 | 2019-2022 | |
| Alcon Vision LLC | $115.98 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $75.58 | 2019 | |
| Glaukos Corporation | $65.21 | 2023 | |
| Sun Pharmaceutical Industries INC. | $53.98 | 2019-2023 | Cequa |
| Biotissue Holdings INC. | $40.69 | 2019 | |
| Ge Healthcare | $27.30 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $23.86 | 2022 | |
| Lensar, INC. | $22.32 | 2019 | |
| Novartis Pharmaceuticals Corporation | $20.06 | 2021 | |
| Sight Sciences, INC. | $16.02 | 2023 | Omni Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.